Your session is about to expire
← Back to Search
Ultrasound Feedback for Lower Back Pain
Phase 2
Waitlist Available
Research Sponsored by National Center for Research Resources (NCRR)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Healthy volunteer
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial is testing whether ultrasound feedback is an effective way to help people learn how to do the abdominal drawing in maneuver (AHE), which is a trunk stabilization exercise used to treat lower back pain.
Who is the study for?
This trial is for healthy volunteers who experience lower back pain. It aims to find the best way to teach abdominal exercises that may help stabilize the spine and reduce pain. There are no specific exclusion criteria provided, suggesting it's open to a broad adult population without other health complications.Check my eligibility
What is being tested?
The study tests how effective different types of feedback are in teaching an abdominal hollowing exercise (AHE) for lower back pain relief. Participants will be divided into three groups: one with no feedback, one with palpation and verbal guidance, and one with additional real-time ultrasound feedback.See study design
What are the potential side effects?
Since this trial involves non-invasive educational techniques rather than medication or surgery, there are likely minimal risks involved. However, some participants might experience discomfort or muscle fatigue from performing the exercises.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Find a Location
Who is running the clinical trial?
National Center for Research Resources (NCRR)Lead Sponsor
537 Previous Clinical Trials
317,016 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
To what degree is this therapy safe for individuals?
"While there is evidence to suggest the treatment's safety, as it only a Phase 2 trial, meaning no efficacy data has been collected yet, our team at Power gave this medication a score of 2."
Answered by AI
Is there an age restriction with regards to participation in this trial?
"Adherent to the eligibility requirements, only those aged 18-60 can partake in this clinical trial."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger